198 related articles for article (PubMed ID: 2534970)
1. Glomerular and urinary heparan sulphate in congenital nephrotic syndrome.
Vermylen C; Levin M; Mossman J; Barratt TM
Pediatr Nephrol; 1989 Apr; 3(2):122-9. PubMed ID: 2534970
[TBL] [Abstract][Full Text] [Related]
2. Glomerular basement membrane heparan sulfate glycosaminoglycan in aminonucleoside of puromycin nephrosis.
Garin EH; Shirey AJ
Child Nephrol Urol; 1988-1989; 9(3):121-6. PubMed ID: 2978121
[TBL] [Abstract][Full Text] [Related]
3. The glycosaminoglycan content of renal basement membranes in the congenital nephrotic syndrome of the Finnish type.
Van den Heuvel LP; Van den Born J; Jalanko H; Schröder CH; Veerkamp JH; Assmann KJ; Berden JH; Holmberg C; Rapola J; Monnens LA
Pediatr Nephrol; 1992 Jan; 6(1):10-5. PubMed ID: 1536728
[TBL] [Abstract][Full Text] [Related]
4. Heparan sulfate--rich anionic sites in the human glomerular basement membrane. Decreased concentration in congenital nephrotic syndrome.
Vernier RL; Klein DJ; Sisson SP; Mahan JD; Oegema TR; Brown DM
N Engl J Med; 1983 Oct; 309(17):1001-9. PubMed ID: 6225948
[TBL] [Abstract][Full Text] [Related]
5. Aberrant proteoglycan composition of the glomerular basement membrane in a patient with Denys-Drash syndrome.
van den Heuvel LP; Westenend PJ; van den Born J; Assmann KJ; Knoers N; Monnens LA
Nephrol Dial Transplant; 1995 Dec; 10(12):2205-11. PubMed ID: 8808212
[TBL] [Abstract][Full Text] [Related]
6. Glycosaminoglycans in urine and amniotic fluid in congenital nephrotic syndrome of the Finnish type.
Ljungberg P
Pediatr Nephrol; 1994 Oct; 8(5):531-6. PubMed ID: 7818994
[TBL] [Abstract][Full Text] [Related]
7. Loss of heparan sulfate proteoglycan from glomerular basement membrane of nephrotic rats.
Mynderse LA; Hassell JR; Kleinman HK; Martin GR; Martinez-Hernandez A
Lab Invest; 1983 Mar; 48(3):292-302. PubMed ID: 6219248
[TBL] [Abstract][Full Text] [Related]
8. Urine glycosaminoglycans in congenital and acquired nephrotic syndrome.
Jadresic LP; Filler G; Barratt TM
Kidney Int; 1991 Aug; 40(2):280-4. PubMed ID: 1942776
[TBL] [Abstract][Full Text] [Related]
9. Reduction of heparan sulphate-associated anionic sites in the glomerular basement membrane of rats with streptozotocin-induced diabetic nephropathy.
van den Born J; van Kraats AA; Bakker MA; Assmann KJ; Dijkman HB; van der Laak JA; Berden JH
Diabetologia; 1995 Oct; 38(10):1169-75. PubMed ID: 8690168
[TBL] [Abstract][Full Text] [Related]
10. Glycosaminoglycans of the glomerular basement membrane in normal and nephrotic states.
Kanwar YS; Rosenzweig LJ; Kerjaschki DI
Ren Physiol; 1981; 4(2-3):121-30. PubMed ID: 7302362
[TBL] [Abstract][Full Text] [Related]
11. Glomerular anionic charge in congenital nephrotic syndrome of the Finnish type.
Ljungberg P; Rapola J; Holmberg C; Holthöfer H; Jalanko H
Histochem J; 1995 Jul; 27(7):536-46. PubMed ID: 7591846
[TBL] [Abstract][Full Text] [Related]
12. Glycosaminoglycans and chylomicron metabolism in control and nephrotic rats.
Staprans I; Felts JM; Couser WG
Metabolism; 1987 May; 36(5):496-501. PubMed ID: 3574136
[TBL] [Abstract][Full Text] [Related]
13. Alterations in proteoglycan metabolism in the nephrotic syndrome induced by the aminonucleoside of puromycin.
Klein DJ; Dehnel PJ; Oegema TR; Brown DM
Lab Invest; 1984 May; 50(5):543-51. PubMed ID: 6232422
[TBL] [Abstract][Full Text] [Related]
14. Increased permeability of the glomerular basement membrane to ferritin after removal of glycosaminoglycans (heparan sulfate) by enzyme digestion.
Kanwar YS; Linker A; Farquhar MG
J Cell Biol; 1980 Aug; 86(2):688-93. PubMed ID: 6447156
[TBL] [Abstract][Full Text] [Related]
15. Undersulfation of glomerular basement membrane heparan sulfate in experimental diabetes and lack of correction with aldose reductase inhibition.
Cohen MP; Klepser H; Wu VY
Diabetes; 1988 Oct; 37(10):1324-7. PubMed ID: 2970980
[TBL] [Abstract][Full Text] [Related]
16. Selective proteinuria in diabetic nephropathy in the rat is associated with a relative decrease in glomerular basement membrane heparan sulphate.
van den Born J; van Kraats AA; Bakker MA; Assmann KJ; van den Heuvel LP; Veerkamp JH; Berden JH
Diabetologia; 1995 Feb; 38(2):161-72. PubMed ID: 7713310
[TBL] [Abstract][Full Text] [Related]
17. Characterization of glycosaminoglycans in urine from patients with nephrotic syndrome and control subjects, and their effects on lipoprotein lipase.
Staprans I; Garon SJ; Hopper J; Felts JM
Biochim Biophys Acta; 1981 Dec; 678(3):414-22. PubMed ID: 6459128
[TBL] [Abstract][Full Text] [Related]
18. Urinary heparan sulfate proteoglycan excretion in black African women with pre-eclampsia.
Khedun SM; Naicker T; Moodley J; Gathiram P
Acta Obstet Gynecol Scand; 2002 Apr; 81(4):308-12. PubMed ID: 11952459
[TBL] [Abstract][Full Text] [Related]
19. [Expression of glomerular heparan sulfate domains in pediatric patients with minimal change nephrotic syndrome].
Dong LQ; Wang Z; Yu P; Guo YN; Wu J; Feng SP; Li S
Sichuan Da Xue Xue Bao Yi Xue Ban; 2009 Jan; 40(1):55-8. PubMed ID: 19292045
[TBL] [Abstract][Full Text] [Related]
20. Enalapril improves albuminuria by preventing glomerular loss of heparan sulfate in diabetic rats.
Reddi AS; Ramamurthi R; Miller M; Dhuper S; Lasker N
Biochem Med Metab Biol; 1991 Feb; 45(1):119-31. PubMed ID: 2015105
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
